The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  McGillivary, Glen ^a   Bakaletz, Lauren O ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PROTEIN SPLUNC1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; GLYCOPROTEIN; PHOSPHOPROTEIN; PLUNC PROTEIN, HUMAN; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SURVIVAL; CHINCHILLA; CONTROLLED STUDY; EARDRUM; GENE EXPRESSION; GENE SILENCING; HAEMOPHILUS INFLUENZAE; HOMEOSTASIS; HOST RESISTANCE; MIDDLE EAR PRESSURE; MUCOCILIARY CLEARANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; UPPER RESPIRATORY TRACT; ANIMAL; BACTERIAL INFECTION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; TRACHEA;

HAEMOPHILUS INFLUENZAE; MAMMALIA;

ANIMALS; BACTERIAL INFECTIONS; CHINCHILLA; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLYCOPROTEINS; HOMEOSTASIS; HUMANS; MODELS, ANIMAL; OTITIS MEDIA; PHOSPHOPROTEINS; RNA, SMALL INTERFERING; SURFACE-ACTIVE AGENTS; TRACHEA;

EID: 78049266320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013224     Document Type: Article

References (46)

1. Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R (2009) Prevention of otitis media: now a reality? Vaccine 27: 5748-5754.
2. Rovers MM (2008) The burden of otitis media. Vaccine 26(Suppl 7): G2-4.
3. Kaplan B, Wandstrat TL, Cunningham JR (1997) Overall cost in the treatment of otitis media. Pediatr Infect Dis J 16: S9-11.
4. Klein JO (1994) Otitis media. Clin Infect Dis 19: 823-833.
5. Bondy J, Berman S, Glazner J, Lezotte D (2000) Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics 105: E72.
6. Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 121: 253-260.
7. Heikkinen T, Chonmaitree T (2003) Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 16: 230-241.
8. Monto AS, Ullman BM (1974) Acute respiratory illness in an American community. The Tecumseh study. Jama 227: 164-169.
9. Bakaletz LO (2002) Otitis Media; Brogden KA, JM Guthmiller, eds. Washington DC: ASM Press. pp 259-298.
10. Jiang Z, Nagata N, Molina E, Bakaletz LO, Hawkins H, et al. (1999) Fimbriamediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect Immun 67: 187-192.
11. Patel J, Faden H, Sharma S, Ogra PL (1992) Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol 23: 15-23.
12. McGuire JF (2002) Surfactant in the middle ear and Eustachian tube: a review. Int J Pediatr Otorhinolaryngol 66: 1-15.
13. Huttner KM, Bevins CL (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45: 785-794.
14. Herr C, Shaykhiev R, Bals R (2007) The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther 7: 1449-1461.
15. Lehrer RI (2004) Primate defensins. Nat Rev Microbiol 2: 727-738.
16. Lim DJ, Chun YM, Lee HY, Moon SK, Chang KH, et al. (2000) Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine 19(Suppl 1): S17-25.
17. Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, et al. (2004) Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 4: 12.
18. McGillivary G, Mason KM, Jurcisek JA, Peeples ME, Bakaletz LO (2009) Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cell Microbiol 11: 1399-1408.
19. Bingle L, Cross SS, High AS, Wallace WA, Devine DA, et al. (2005) SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype. J Pathol 205: 491-497.
20. Garcia-Caballero A, Rasmussen JE, Gaillard E, Watson MJ, Olsen JC, et al. (2009) SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci USA 106: 11412-11417.
21. Ghafouri B, Kihlstrom E, Stahlbom B, Tagesson C, Lindahl M (2003) PLUNC (palate, lung and nasal epithelial clone) proteins in human nasal lavage fluid. Biochem Soc Trans 31: 810-814.
22. Di YP, Harper R, Zhao Y, Pahlavan N, Finkbeiner W, et al. (2003) Molecular cloning and characterization of spurt, a human novel gene that is retinoic acidinducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 278: 1165-1173.
23. Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, et al. (2007) Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Respir Res 8: 79.
24. Bingle CD, Bingle L (2000) Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta 1493: 363-367.
25. Zhou HD, Li XL, Li GY, Zhou M, Liu HY, et al. (2008) Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell Biochem 309: 191-197.
26. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, et al. (2007) Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J Immunol 179: 3995-4002.
27. Bartlett JA, Hicks BJ, Schlomann JM, Ramachandran S, Nauseef WM, et al. (2008) PLUNC is a secreted product of neutrophil granules. J Leukoc Biol 83: 1201-1206.
28. Gakhar L, Bartlett JA, Penterman J, Mizrachi D, Singh PK, et al. PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 5: e9098.
29. Gazzano-Santoro H, Parent JB, Grinna L, Horwitz A, Parsons T, et al. (1992) High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 60: 4754-4761.
30. Ghafouri B, Kihlstrom E, Tagesson C, Lindahl M (2004) PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 1699: 57-63.
31. Jung HH, Chae SW, Jung SK, Kim ST, Lee HM, et al. (2003) Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma. Laryngoscope 113: 432-435.
32. Shimada J, Moon SK, Lee HY, Takeshita T, Pan H, et al. (2008) Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniaeinduced otitis media. BMC Infect Dis 8: 134.
33. Novotny LA, Jurcisek JA, Godfroid F, Poolman JT, Denoel PA, et al. (2006) Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. Vaccine 24: 4804-4811.
34. Caye-Thomasen P, Tos M (2004) Eustachian tube gland changes in acute otitis media. Otol Neurotol 25: 14-18.
35. Glasser SW, Senft AP, Whitsett JA, Maxfield MD, Ross GF, et al. (2008) Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 181: 621-628.
36. McDonald RE, Fleming RI, Beeley JG, Bovell DL, Lu JR, et al. (2009) Latherin: a surfactant protein of horse sweat and saliva. PLoS One 4: e5726.
37. Bakaletz LO, Griffith SR, Lim DJ (1989) Effect of prostaglandin E2 and bacterial endotoxin on the rate of dye transport in the Eustachian tube of the chinchilla. Ann Otol Rhinol Laryngol 98: 278-282.
38. Grimm D, Kay MA (2007) Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 117: 3633-3641.
39. McGillivary G, Ray WC, Bevins CL, Munson RS, Jr., Bakaletz LO (2007) A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol 44: 2446-2458.
40. Harris RH, Wilk D, Bevins CL, Munson RS, Jr., Bakaletz LO (2004) Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway. J Biol Chem 279: 20250-20256.
41. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
42. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, et al. (2006) Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci USA 103: 9178-9183.
43. Bingle CD, LeClair EE, Havard S, Bingle L, Gillingham P, et al. (2004) Phylogenetic and evolutionary analysis of the PLUNC gene family. Protein Sci 13: 422-430.
44. Mason KM, Munson RS, Jr., Bakaletz LO (2005) A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun 73: 599-608.
45. Margolis RH, Hunter LL, Giebink GS (1994) Tympanometric evaluation of middle ear function in children with otitis media. Ann Otol Rhinol Laryngol Suppl 163: 34-38.
46. Seilly DJ (1982) A chemical test to determine the end point of EDTA decalcification. Med Lab Sci 39: 71-73.